Record any deviations from normal protocol and inform the team post-operatively regarding the GLP-1 exposure so recovery plans and glucose targets can be modified
Specific compatibility considerations include confirmation of absence of reducing agents for disulphide-containing peptides, BSA carrier supplementation for recombinant proteins, and acetic acid acidification for hydrophobic peptides requiring low pH solubilisation
04Keep the Same Tracker If the Plan Changes Later A perimenopause-related plan can change over time
Zhou Y, Bendor J, Hofmann L, Randesi M, Ho A, Kreek MJ
Electrolytes are not a replacement for medical care or nutrition, but the right formula may help support hydration depending on the specific challenges you may be experiencing on GLP-1 therapy
Eliminate Drugs and Be Mindful of Other Stimulants Identifying palpitation triggers is important to prevent occurrences because what may induce your palpitations may not be the same for another person